Can better teamwork in pediatric clinics improve care for kids with ADHD and behavior issues?

NCT ID NCT04946253

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at how to help pediatric primary care offices better use a proven program called DOCC for children with behavior problems and ADHD. The program involves counseling and support for families. Researchers will compare different strategies to help clinic teams adopt and deliver this care. About 450 participants, including doctors, care managers, and families, will take part across up to 24 clinics in Pennsylvania.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Doctor Office Collaborative Care (DOCC) – a behavioral treatment program for disruptive behavior and ADHD, delivered in primary care
What this could lead to
If successful, this could show how to make evidence-based mental health care for children more widely available in regular doctor's offices.
What could go wrong
This is an implementation study, not a test of a new drug or cure. It focuses on how well clinics adopt the program, not on whether the program itself works better than other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Drexel University

    NOT_YET_RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • University of Pittsburgh

    RECRUITING

    Pittsburgh, Pennsylvania, 15260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.